Thu. November 19, 2009
-
PR Web (press release)
November 17, 2009
Overuse of the common "daily supplement" folic acid can actually block
Alimta's therapeutic benefit. This is a risk no
mesothelioma patient should undertake ...
Indianapolis Star
November 14, 2009
For years, Lilly has been a fairly small player in oncology, with just two drugs,
Alimta for
lung cancer and
Gemzar as a chemotherapy drug for various ...
Media Newswire (press release)
November 11, 2009
Data from a late-stage trial reporting that maintenance therapy with pemetrexed ( Alimta ) extends survival for patients with nonsquamous forms of advanced ...
Pharma Times
November 10, 2009
Alimta sales are soaring, up 47% to $462 million in the third quarter, and Dr Lechleiter claimed it still has plenty of room to grow. ...
MedPage Today
November 9, 2009
Maintenance therapy with pemetrexed (
Alimta) significantly improved survival in patients with stage IIIB or IV nonsquamous, nonsmall-cell
lung cancer ...
GlobeNewsWire (press release)
November 9, 2009
TRC102 is currently being studied as an oral agent in combination with pemetrexed (Alimta(R)) and as an intravenous agent in combination with temozolomide ...
Reuters
November 9, 2009
He cited expectations of growing sales from
cancer drug
Alimta, antidepressant
Cymbalta, anti-impotence treatment
Cialis and recently approved blood-clot ...
The Guardian (Australia)
November 3, 2009
... fighting for justice for fellow victims and forcing Tony Abbott to make the anti-
cancer drug,
Alimta, freely available to sufferers of
mesothelioma. ...
Stevens Institute of Technology The Stute
October 30, 2009
The Food and Drug Administration approved the
molecule now referred to as
Alimta after 13 years of tests and trials.
Alimta stands as the only drug for ...
newjerseynewsroom.com
October 29, 2009
Eli Lilly is
marketing it under the name
Alimta. "This is possible because of the support and help I have received from
students and colleagues who have ...
Asbestos.com
October 28, 2009
Chemotherapy drugs for peritoneal patients have included but are not limited to cisplatin, doxorubicin, carboplatin and pemetrexed (Alimta). ...
Charleston Post Courier
October 24, 2009
We have products like the
cancer treatment
Alimta, like our insulin franchise and some other things that we know will also be growing. ...
News Sentinel
October 22, 2009
The company's second-best seller, the antidepressant
Cymbalta, showed 10 percent growth, while sales for
cancer drug
Alimta climbed 47 percent to $462 ...
Reuters
October 22, 2009
...
Humalog (16% growth to $500 million),
Alimta (47% growth to $462 million).
wells Fargo Surprises Yet Again Before the
market opened
Wednesday morning, ...
Mesothelioma News
October 22, 2009
A recent clinical trial showed that the
cancer drug
Alimta improved the survival of
lung cancer patients by nearly three months, compared to those who were ...
Pharma Times
October 22, 2009
The most striking performances came from
Cymbalta (duloxetine), up 10% to $790.2 million and
Alimta (pemetrexed) which leapt 47% to $461.9 million. ...
路透中国
October 21, 2009
Seeking Alpha (blog)
October 21, 2009
Japan's volume growth was largely driven by
Alimta, which was approved earlier this year for both first line and second line non-small cell
lung cancer. ...
American Chronicle
October 21, 2009
For the third quarter of 2009, Alimta generated sales of $461.9 million, an increase of 47 percent compared with the third quarter of 2008. ...
Reuters South Africa
October 21, 2009
Drugmaker
Eli Lilly and Co posted better-than-expected profit, aided by higher sales of its
Cymbalta anti-depressant and
Alimta cancer drug, and boosted its ...
Reuters
October 21, 2009
Alimta For the third quarter of 2009, Alimta generated sales of $461.9 million, an increase of 47 percent compared with the third quarter of 2008. ...
FiercePharma
October 21, 2009
... on higher demand and higher prices; the antipsychotic
Zyprexa, antidepressant
Cymbalta, ED remedy
Cialis, and
cancer drug
Alimta all posted gains. ...
Seeking Alpha (blog)
October 21, 2009
...
Zyprexa (3% growth to $1.2 billion),
Cymbalta (10% growth to $790.2 million),
Humalog (16% growth to $500 million),
Alimta (47% growth to $462 million). ...
Reuters
October 20, 2009
Shares of
Pfizer Inc (PFE.N) rose in premarket trading on
Tuesday after the Dow component reported adjusted third-quarter earnings that beat expectations. ...
Seeking Alpha (blog)
October 19, 2009
... the addressable
market but it can also dramatically increase chances for approval and market acceptance, similar to the case in Lilly's
Alimta. ...
Reuters
October 19, 2009
... to chemotherapeutics, began dosing in 2008 in a Phase 1 trial in combination with Temodar(R) and a Phase 1 trial in combination with Alimta(R). ...
The Daily Deal
October 19, 2009
Cowen expects strong third-quarter growth from
Alimta (+27% to $400 million),
Cymbalta (+15% to $825 million),
Humalog (+9% to $470 million) and
Cialis (+4% ...
데일리메디
October 15, 2009
릴리ì“ ë¹ÂìÂÂì± ÃÂÂìÂÂ" ÃÂÂìÂÂ"ì Âì¸ ìÂÂ림à주(Alimta, ì±ë¶Âëª..._pemetrexed)ì ìÂÂìÂÂì-°êµ¬ë¥¼ ì§ÂÃÂ-ÂÃÂÂê³ ìÂÂëÂÂ" ì-°ì¸ë ì¸ë¸ÂëÂÂì¤ë³Â'ì ìÂÂ"ì¼Ã°갠미굠ìÂÂÃÂ'ÂìÂÂì½êµÂ(FDA)ì ì½젠ìÂÂì ...
TransWorldNews (press release)
October 14, 2009
... but newer chemotherapy drugs like
Alimtaî are beginning to show some promise in the successful treatment of this difficult-to-fight
cancer. ...
Journal and Courier
October 14, 2009
What it makes: The active pharmaceutical ingredients for Lilly products including
Gemzar,
Alimta and
Cialis. Size: Tippecanoe Labs consists of 128 buildings ...
MesotheliomaHelp.net
October 13, 2009
The University Health Network of Toronto is currently recruiting participants for a clinical trial using a combination of Pemetrexed (Alimta) with Cisplatin ...
TransWorldNews (press release)
October 6, 2009
While certain conventional
cancer treatment methods, such as chemotherapy and the use of the drug
Alimtaî have been known to extend the life of some ...
Asbestos.com
October 1, 2009
The makers of the drug
Alimta announced September 28, 2009 that the medication prolonged the lives of
lung cancer patients by three months in a recent ...
BloggingStocks (blog)
October 1, 2009
Look for Lilly to post a 5-7% revenue gain in F2009, led by growth in sales of branded drugs
Cymbalta,
Humalog,
Cialis, and
Alimta. ...
MesotheliomaHelp.net
September 29, 2009
Eli Lilly and Co. announced this month that their drug
Alimta has extended the life of
lung cancer patients by about three months. ...
Mesothelioma & Asbestos Awareness Center
September 29, 2009
No cure exists, but chemotherapy, surgery, and drugs like Alimtaî may improve quality of life for those suffering from this disease. ...
Zikkir World (blog)
September 26, 2009
This Phase III clinical trial supported previous studies looking at the use of histology to tailor treatment with Alimta for patients with advanced ...
Pblico.pt
September 25, 2009
Dá o exemplo de dois fármacos em concreto: o Avastin (
dos laboratórios Roche) eo
Alimta (dos laboratórios
Eli Lilly), ambos usados como primeira linha de ...
World Market Media (blog)
September 25, 2009
Not since my work on
Alimta(r) and
Gemzar(r) at Lilly have I been this excited about a compound."
lung cancer accounts for more than 1200000 new cases ...
Pharma Times
September 24, 2009
... guidances including Janssen-Cilag's Stelara for psoriasis,
Eli Lilly's
Alimta for non-small cell
lung cancer, and
Pfizer's Sutent for stomach tumours. ...
